Cargando…

HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis

OBJECTIVE: Whether lowering glycosylated haemoglobin (HbA1c) level below 7.0 % improves macro-vascular outcomes in diabetes remains unclear. Here, we aimed to assess the effect of relatively tight glucose control resulting in a follow-up HbA1c level of less or more than 7.0 % on cardiovascular outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pin, Huang, Rong, Lu, Sen, Xia, Wenqing, Sun, Haixia, Sun, Jie, Cai, Rongrong, Wang, Shaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578327/ https://www.ncbi.nlm.nih.gov/pubmed/26392171 http://dx.doi.org/10.1186/s12933-015-0285-1

Ejemplares similares

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke
por: Matz, Karl, et al.
Publicado: (2020)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
por: Yang, Chun-Pai, et al.
Publicado: (2020)

HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
por: Hjellestad, Iren D, et al.
Publicado: (2013)

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c
por: Karayiannides, Stelios, et al.
Publicado: (2021)

Clinical and Economic Benefits Associated With the Achievement of Both HbA(1c) and LDL Cholesterol Goals in Veterans With Type 2 Diabetes
por: Shi, Lizheng, et al.
Publicado: (2013)

The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes
por: Katwal, Prakash C, et al.
Publicado: (2020)

RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study
por: Wang, Pin, et al.
Publicado: (2016)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion
por: Bajaj, Sarita, et al.
Publicado: (2019)

An Evaluation of Point-of-Care HbA1c, HbA1c Home Kits, and Glucose Management Indicator: Potential Solutions for Telehealth Glycemic Assessments
por: Zaharieva, Dessi P., et al.
Publicado: (2022)

Individualized HbA(1c) Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey
por: Lautsch, Dominik, et al.
Publicado: (2021)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China
por: Hu, Chengping, et al.
Publicado: (2020)

A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1(C)
por: Ma, Jing, et al.
Publicado: (2021)

Advanced Glycation End Product-Induced Astrocytic Differentiation of Cultured Neurospheres through Inhibition of Notch-Hes1 Pathway-Mediated Neurogenesis
por: Guo, Yijing, et al.
Publicado: (2013)

Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
por: Yang, Chen Die, et al.
Publicado: (2020)

Association of Serum Uric Acid with 2-Hour Postload Glucose in Chinese with Impaired Fasting Plasma Glucose and/or HbA1c
por: Fan, Hong-Qi, et al.
Publicado: (2013)

Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
por: Jeon, Ja Young, et al.
Publicado: (2013)

A View Beyond HbA1c: Role of Continuous Glucose Monitoring
por: Chehregosha, Haleh, et al.
Publicado: (2019)

Effect of biological variation in HbA1c and blood glucose on the diagnosis of prediabetes
por: Hempe, James M., et al.
Publicado: (2023)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes
por: Yang, Chen-Yi, et al.
Publicado: (2020)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c
por: Gallwitz, Baptist, et al.
Publicado: (2017)

Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore
por: Lim, Wei-Yen, et al.
Publicado: (2018)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Postprandial Blood Glucose Outweighs Fasting Blood Glucose and HbA1c in screening Coronary Heart Disease
por: Jiang, Jingjing, et al.
Publicado: (2017)

Toothbrushing, Blood Glucose and HbA1c: Findings from a Random Survey in Chinese Population
por: Su, Lingyu, et al.
Publicado: (2016)

Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c
por: Nomura, Kyoko, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lhuhavn9r552nfn3bgq08vs48u